US 8658778
hTMC promoter and vectors for the tumor-selective and high-efficient expression of cancer therapeutic genes
granted A61KA61K48/0058A61P
Quick answer
US patent 8658778 (hTMC promoter and vectors for the tumor-selective and high-efficient expression of cancer therapeutic genes) held by The Board of Regents of the University of Texas System expires Mon Feb 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Feb 25 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 35
- CPC classes
- A61K, A61K48/0058, A61P, A61P35/00, A61P35/02